Cell and Gene Therapy Catapult, University of Aberdeen gene/cell therapy, endocrine/metabolic news

Cell and Gene Therapy Catapult (CGT) and University of Aberdeen formed newco Islexa Ltd. (London, U.K.) to develop cell therapy technology to treat Type I diabetes. The technology would enable reprog...